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devices. The 95% agreement exceeded the limits for FEV 1 by 
50 ml in 2 EO spirometers. The EO interdevice comparisons 
showed mean differences and limits of agreement within 
established thresholds, thus indicating fair accuracy when 
comparing devices. Repeats with the same spirometer did 
not result in statistically significant differences.  Conclu-
sions: This study suggests fair agreement between the 
handheld and the conventional spirometer. Differences 
slightly exceeding limits for FEV 1 in 2 EO devices might be 
considered mostly irrelevant for clinical practice. However, 
the systematically lower FVC and FEV 1 observed with EO 
may be significant for epidemiological studies, thus justify-
ing inspection before replacing devices. 
 Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Spirometric lung function values are relatively easy to 
measure and have long been proven as excellent objective 
markers of respiratory morbidity and life expectancy. 
Hence, the use of spirometry is highly attractive and has 
often been included in cohort studies aiming to follow the 
same participants at the long term. However, such studies 
might be confronted at times with the need for spirometer 
replacement. The same applies to certified pulmonary 
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 Abstract 
 Background: Long-term cohort studies and lung function 
laboratories are confronted with the need for replacement 
of spirometers. Lack of agreement between spirometers 
might affect the longitudinal comparison of data, notably 
when replacing conventional by portable spirometers.  Ob-
jectives: To compare the handheld EasyOne (EO) with the 
conventional SensorMedics (SM) spirometer, and to analyze 
the interdevice reproducibility of EO spirometers.  Methods: 
In total, 82 volunteers completed spirometry sessions with 
1 SM and 2 of 3 EO spirometers following a Latin square de-
sign. Analyses of differences in forced vital capacity (FVC), 
forced expiratory flow in 1 s (FEV 1 ), FEV 1 /FVC and mean 
forced expiratory flow calculated between 25 and 75% of 
the FVC between spirometers used a mixed effect model 
with a random intercept for each subject and the effect of 
the device as fixed effect adjusted for sex, age, height and 
order of spirometer tested. Bland-Altman plots show the 
95% limits of agreement.  Results: Comparisons between EO 
and SM showed relatively small mean differences of <3%, 
but systematically lower values for FVC and FEV 1 in all EO 
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function laboratories which are required to adopt the best 
available technology in order to ensure quality control. Yet, 
the replacement of long-lasting spirometers may reveal 
challenging for longitudinal and retrospective compari-
sons of data both in epidemiological studies and in clinical 
practice. Evaluating the agreement between the new and 
the dated spirometer to be replaced is therefore essential 
for the correct interpretation of longitudinal results.
 Several studies have assessed the comparability be-
tween spirometers meeting the American Thoracic Soci-
ety (ATS)/European Respiratory Society (ERS) recom-
mendations both in clinical and epidemiological settings 
 [1–6] . Differences between spirometers reported in these 
studies varied from 0.07 to 0.41 liters (forced vital capac-
ity, FVC) and from 0.05 to 0.11 liters (forced expiratory 
flow in 1 s, FEV 1 ). Variation between spirometers may 
relate to the characteristics of the devices but also to the 
design and the setting of the study, the underlying disease 
of patients enrolled in the assessment, the degree of com-
pliance of subjects performing spirometric tests and the 
technicians. To date, no study has published the potential 
need for correction of spirometric values when differenc-
es between devices are detected. Yet, systematic errors 
due to intrinsic discrepancies found between spirometers 
might introduce bias when analyzing the intrasubject 
variation over time. For example, mild chronic obstruc-
tive pulmonary disease could be under- or overdiagnosed 
depending on the direction of the bias. 
 In recent years, a number of different last-generation 
portable spirometers has been released and increasingly 
adopted for clinical diagnosis and field studies, mainly 
for their ease of handling and lower costs. Among them, 
the handheld ndd EasyOne TM (EO) flow-sensing spi-
rometer is reputed for its reliability, no need for calibra-
tion, automated quality checks and electronic storage of 
results  [7, 8] . This spirometer was chosen by the large 
multinational epidemiological BOLD (Burden of Ob-
structive Lung Disease) study, which confirmed its reli-
ability by showing comparable quality results among 
widely geographically separated centers  [9, 10] . Howev-
er, cross-validation studies comparing EO with other 
standard spirometers showed contrasting results with in-
sufficient agreement reported between devices for FVC 
 [6] or FEV 1  [11] . Replication studies may therefore be 
needed in order to confirm the validity of this instru-
ment. Furthermore, the interdevice reproducibility of 
the EO has not been reported yet.
 In the context of the 3rd survey of the SAPALDIA 
(Swiss Study on Air Pollution and Health in Adults) 
study in 2010/2011, there was a need for the replacement 
of the SensorMedics (SM) 2200 flow-sensing spirome-
ters after nearly 20 years since the first examination of 
the cohort participants. The decision was taken to re-
place the dated spirometers from the 8 centers of the 
study with the handheld EO spirometer, and each site 
was equipped with 2 or 3 such devices depending on the 
expected number of participants. In order to examine 
the comparability of spirometers across the two brands 
and between EO devices, we conducted a nested study 
in 82 healthy nonsmoking volunteers. The primary ob-
jectives of the study were twofold: (1) to compare the 
agreement between the conventional SM and the hand-
held EO spirometer and (2) to analyze the interdevice 
reproducibility of the EO spirometer using 3 devices 
randomly selected from the SAPALDIA centers. In ad-
dition, we also tested the intradevice reproducibility of 
all spirometers.
 Material and Methods 
 Setting 
 The study was conducted as a nested project of SAPALDIA. 
Details on the SAPALDIA study were published previously  [12, 
13] . Briefly, the study started in 1991 (S1) with the cross-sectional 
survey of 9,651 participants in 8 different regions of Switzerland 
reflecting the geographic, climatic, linguistic and cultural diversity 
of the country. The primary study objectives were to assess respira-
tory health and its dependence on air pollution in a representative 
sample of the population. Spirometry was an essential outcome at 
baseline, and in the 2002/2003 (S2) and the 2010/2011 (S3) follow-
up surveys. Eight teams of trained technicians conducted all ex-
aminations following the same methods.
 The current study was carried out at the University Hospitals 
of Geneva, which is 1 of the 8 SAPALDIA centers.
 Subjects 
 Eighty-five healthy nonsmoking volunteers answered to an ad-
vertisement posted at the University Hospital and the Faculty of 
Medicine. Eligibility criteria were absence of respiratory and car-
diovascular disease, no regular intake of respiratory or cardiovas-
cular medication and being a never-smoker (defined by SAPAL-
DIA as ‘not having smoked more than 20 packs of cigarettes in 
life’). Excluded from the analyses were 2 subjects with poor com-
pliance and 1 subject presenting with abnormal spirometric re-
sults. 
 Design 
 The study tested 4 spirometers (1 SM and 3 EO). Subjects qual-
ifying for examinations were invited for a 2-hour visit to perform 4 
series of full spirometry sessions using 3 different spirometers and 
1 repeat session using 1 of the 3 devices (duplicate session). The du-
plicate session served to test the reproducibility of each instrument, 
thus we included 1 of the 3 spirometers in each test sequence. The 
sequence of spirometers was predefined following a Latin square 
design, and each sequence included 1 SM and 2 EO spirometers.
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 The calibration of the SM device and the volume checking of 
the EO devices were performed daily using a 3-liter certified sy-
ringe according to the ATS/ERS and the manufacturer recommen-
dations  [14] .
 The protocol of the study was approved by the Ethical Com-
mittee of the University Hospitals of Geneva. Consent for partici-
pation was obtained from all subjects enrolled in the study.
 Spirometers and Spirometric Parameters 
 The spirometers used in the study were the SM 2200 (Sensor-
Medics, Yorba Linda, Calif., USA), an open system device equipped 
with a mass heated wire flow sensor, and the EO (ndd Medical Tech-
nologies, Zurich, Switzerland), a handheld device equipped with an 
ultrasonic sensor to measure flow, both meeting ATS/ERS standards 
 [14, 15] . Recommended disposable mouthpieces with filters were 
used for all spirometries. The SM spirometer was retrieved from the 
spirometers used during the first 2 SAPALDIA surveys (1991 and 
2002/2003). All EO devices belonged to the equipment used during 
the3rd SAPALDIA survey (2010/2011). Two from these were used 
since the beginning of this study and a 3rd device was added later.
 According to the standardized operational procedures of SA-
PALDIA, a minimum of 3 and a maximum of 8 tests per device 
were performed in each subject. The 3 best spirometric maneuvers 
were recorded for analyses. Accordingly, for a session to be repro-
ducible, the difference between the 2 largest FVC and the 2 largest 
FEV 1 had to be within 0.100 liters or 5%. These criteria were based 
on the ATS recommendations published in 1987 and adopted by 
SAPALDIA in 1991  [16] . The 2 subsequent SAPALDIA surveys 
maintained the same criteria concerning the reproducibility of 
FVC and FEV 1 ; all EO spirometers used in S3 had their configura-
tion changed by the manufacturer to be in agreement with these 
previous standards. In the present study, the criterion used for re-
producibility of FVC and FEV 1 followed the same standards.
 The quality control of all spirometric maneuvers was automat-
ically displayed on the computer screen (SM) or the device (EO). 
Quality degrees from A (best) to E (worst) are provided by EO at 
the end of each test. We considered only spirometries with highest 
degrees A and B for this study.
 The following lung function parameters were analyzed: FVC, 
FEV 1 , FEV 1 /FVC ratio and mean forced expiratory flow calculated 
between 25 and 75% of the FVC (FEF 25–75 ). The FVC and FEV 1 
were recorded from the highest value among all accepted curves. 
The FEV 1 /FVC ratio was calculated from the best FEV 1 and the 
best FVC, whereas the FEF 25–75 was recorded from the best curve 
with the largest sum of FEV 1 and FVC. All spirometries were per-
formed by one nurse trained as a fieldworker for S3 examinations 
in the center of Geneva. Supervision of the spirometry tests was 
assured by an experienced pulmonologist who is also part of the 
SAPALDIA team.
 Analyses 
 Lung function results are reported using absolute and percent of 
predicted values based on the SAPALDIA reference equations de-
veloped by Brändli et al.  [17] . Characteristics of subjects and spiro-
metric results obtained for each spirometer are expressed as means 
± SD. Differences between spirometers are expressed as means for 
all spirometric parameters. To test the effect of the sequence of spi-
rometries performed by subjects using the Latin square design, a 
Wald test was applied to the mixed effect model with a random ef-
fect for subjects and with the sequence as the only fixed effect. 
Paired t  tests were used to test the reproducibility of spirometers by 
comparing the results obtained from spirometry tests using the 
same device. To compare differences between spirometers in FVC, 
FEV 1 , FEV 1 /FVC and FEF 25–75 results, we used a mixed effect mod-
el with a random intercept for each subject and the effect of the de-
vice as fixed effect adjusted for sex, age, height and order of spirom-
eter tested. As suggested by the analysis of residuals of the models 
for FVC, FEV 1 /FVC and FEF 25–75 , we modeled heteroscedasticity 
by allowing the variance in the residuals to change with the fitted 
values of the model  [18] . We also tested two mixed effect models, 
one with an additional random slope effect for each subject to mod-
el an eventual temporal trend due to the sequence order and one 
with a first order autoregressive covariance structure of errors with-
in each subject. These two models gave similar estimates and stan-
dard errors as the one with a random intercept only.
 The agreement between spirometers was assessed using the 
Bland-Altman method  [19] with plots displayed by sex as a proxy 
of lung volume. For comparisons of absolute differences between 
instruments, we considered the ATS standards of accuracy for 
monitoring devices  ≤ 0.100 liters or ±3% for FVC and FEV 1 , and 
 ≤ 0.200 l/s or ±5% for FEF 25–75  [14] . The interpretation of the lim-
its of agreement was based on criteria setting the threshold at 0.500 
(FVC) and 0.350 liters (FEV 1 ), as reported by Liistro et al.  [6] .
 All analyses were performed using R for Windows version 
2.15.1  [20] with the packages NMLE  [21] for the mixed effect mod-
els, and MethComp  [22] and ggplot2  [23] for the Bland-Altman 
plots. The significance level was fixed at 5% (two tailed).
 Results 
 The study was carried out from July 7 to November 3, 
2011. A total of 82 subjects (mean age 24.1 ± 7.1 years) 
completed trials with at least 3 different spirometers fol-
lowing the preestablished sequence. Each session consist-
ed of 3–8 spirometric maneuvers. In total, 357 sessions 
(average of 89 sessions per device) were performed (112 
for SM, 105 for EO1, 102 for EO2 and 38 for EO 3, which 
was added later to the study).  Table 1 summarizes the de-
mographic characteristics and the lung function param-
eters of subjects enrolled in the study.  Table 2 depicts the 
mean lung function results for each spirometer.
 Quality Control of Tests and Design 
 The quality control of spirometries showed that 90% 
of the SM tests achieved the highest quality according to 
ATS/ERS guidelines  [14] . For EO, highest quality control 
codes (level A = 2005 ATS/ERS quality criteria: 3 accept-
able maneuvers and 2 highest FEV 1 and FVC within 150 
ml) were achieved in 91% of tests performed with EO1, 
86% with EO2 tests and 90% with EO3. 
 The order of spirometer testing had no detectable effect 
on FVC, FEV 1 , FEV 1 /FVC and FEF 25–75 (all p > 0.7). Dif-
ferences in results obtained by repeated measures with the 
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same spirometer were also not statistically significant. The 
averaged absolute differences between the 1st and the 2nd 
measurements for all spirometers were: FVC = 0.001 liters 
(p = 0.928), FEV 1 = 0.001 liters (p = 0.917), FEV 1 /FVC = 
0.03% (p = 0.872) and FEF 25–75 = 0.026 l/s (p = 0.839). 
 To take into account circadian fluctuations in lung 
function values, we also tested whether results depended 
on the time of the day of spirometric measurements. The 
mixed model with an indicator for morning/afternoon 
measurement time revealed no significant interaction be-
tween time of the day and device for FVC [coefficient of 
variation (CV) = 0.157, SE = 0.125, p value = 0.214], FEV 1 
(CV = 0.093, SE = 0.100, p value = 0.357), FEF 1 /FVC (CV 
= –0.723, SE = 1.258, p value = 0.567) or FEF 25–75 (CV = 
0.014, SE = 0.197, p value = 0.945).
 Comparisons between Spirometers 
 The comparisons between the SM and the EO are 
shown in  table 3 . Overall, mean differences were relative-
ly small, but systematically lower values were observed for 
FVC and FEV 1 in the 3 EO spirometers compared to the 
SM, with the difference slightly exceeding the 100-ml 
threshold for FVC when comparing EO1 to SM. All per-
cent differences were within 3%. Mean differences in the 
FEV 1 /FVC ratio were close to 0 and varied between 0.00 
and 0.08 l/s in FEF 25–75 . 
 Bland-Altman plots for limits of agreement stratified 
by sex in all considered spirometric parameters are dis-
played in  figures 1 and  2 . Limits of agreement (lower 
bound) exceeded the threshold criterion of 350 ml for 
FEV 1 in comparisons of the SM with the EO1 and the 
EO3. Wider variations were observed for FEF 25–75 with 
mean relative differences of 2.9% comparing SM and 
EO2, and limits of agreement globally larger than those 
observed for FVC and FEV 1 . To examine whether the 
agreement depended on lung volumes, we regressed the 
difference between devices on the spirometric parame-
ters. Results were statistically significant for FVC [β: 
–0.048 (0.016), R 2 : 0.147; p value 0.004] and FEV 1 [β: 
–0.046 (0.021), R 2 : 0.144; p value 0.027] comparing SM 
and EO1, and FEF 25–75 comparing SM and EO1 [β: –0.102 
(0.038), R 2 : 0.351; p value 0.010], and SM and EO2 [β: 
–0.110 (0.040), R 2 : 0.369; p value 0.008].
 Table 4 shows the pairwise comparisons of the EO spi-
rometers. Though statistically significant, the mean dif-
ferences between devices were within tolerated thresh-
olds for all spirometric parameters, indicating fair accu-
racy when comparing devices. The limits of agreement 
were within the specified standards for FVC and FEV 1 in 
all EO spirometers ( tables 3 ,  4 ). However, the mean dif-
ference and the upper bound of the 95% confidence in-
terval reached limits for FVC when comparing EO2 with 
EO1. 
Table 1.  Characteristics of the study participants (means ± SD)
All (n = 82) Men (n = 38) Women (n = 44)
Age, years 23.6±7.4 24.6± 10.0 22.8± 3.9
Height, cm 172.2±9.1 178.7±7.4 166.5±6.2
Weight, kg 66.2±13.0 74.3±12.3 59.1±8.5
BMI 22.2±3.1 23.24±3.3 21.30±2.6
FVC, liters 4.6±1.0 (97.1±11.0) 5.5±0.8 (97.3±11.0) 4.0±0.5 (97.0±11.0)
FEV1, liters 3.9±0.8 (97.1±11.0) 4.6±0.6 (97.0±10.0) 3.4±0.3 (97.3±10.5)
FEV1/FVC, % 85.1±6.1 (100.7±6.6) 83.5±5.7 (100.6±6.4) 86.5±6.2 (100.8±6.7)
FEF25–75, l/s 4.2±1.0 (100.1±20.4) 4.7±1.1 (99.9±20.0) 3.8±0.7 (101.1±20.8)
 Percentages of predicted values for FVC, FEV1, FEV1/FVC and FEF25-75 are given in parentheses based on equations for the Swiss 
population from Brändli et al. [16].
Table 2.  Spirometry results (means ± SD) obtained with SM and 
EO spirometers in 82 healthy, nonsmoking volunteers
Parameter SM EO1 EO2 EO3
FVC, liters 4.7±1.1 4.5±1.0 4.7±1.0 4.5±0.9
FEV1, liters 4.0±0.8 3.9±0.8 4.0±0.8 3.8±0.6
FEV1/FVC, % 84.7±6.3 85.4±5.9 85.7±6.0 84.0±6.8
FEF25–75, l/s 4.2±1.1 4.2±1.0 4.4±1.0 4.0±0.9
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 Discussion 
 Findings from this study show an overall good quality 
of the large number of spirometries performed on a single 
occasion by healthy and mostly young never-smokers. In 
this ideal context, comparisons between spirometers from 
different brands and within the same brand showed satis-
factory agreement. Reading differences were lower than 
the generally tolerated thresholds for the majority of com-
parisons. However, systematic deviations in FVC and 
FEV 1 were observed between the SM and the EO devices. 
 Several studies reported on the quality of spirometric 
tests performed with the EO both in clinical  [7, 24] and 
epidemiological  [10, 25] settings. The excellent reproduc-
ibility of FVC and FEV 1 parameters within our subjects 
is in line with these reports. Unquestionably, reliable, 
high-quality tests are a prerequisite of a spirometer, and 
the vast experience gathered worldwide over the last years 
with the EO largely confirms its utility. 
 To further assess EO performance, we compared it to 
the SM spirometer used in SAPALDIA in the past. The 
latter had been tested in a comparison of lung function 
measurements made during ECRHS (European Commu-
nity Respiratory Health Survey), and differences among 
equipments of different brands used in the study were not 
statistically significant  [26] . SAPALDIA (Basel) is part of 
the ECRHS and used the same SM equipment as several 
other centers of the European study. Furthermore, the 
performance of the SM spirometers used in the 2 first sur-
veys of SAPALDIA was validated and the variability 
across 8 spirometers was <3% for FVC, FEV 1 and FEF 50 
 [27, 28] . Specifically for the SM used in the current study, 
the device deviation from the personal mean had been of 
the order of 1%. In all, these studies point to the fair re-
producibility of the SM equipment. 
 Barr et al. [11] elegantly tested the EO using an in-line 
waveform generator and performed a clinical compari-
son with the SM 2130, a model similar to ours. As in our 
study, spirometric parameter values derived from the EO 
were lower than those of the SM. Furthermore, the au-
thors report limits of agreement exceeding the preestab-
lished criteria for the FEV 1 , but not for the FVC, findings 
which we corroborate in this study. 
 Mean differences in FEV 1 between SM and EO were 
on average 100 and 50 ml in the study by Barr et al.  [11] 
and in ours, respectively. Standards for judging the mag-
nitude of error and the potential need for correction of 
spirometric measurements derived from different equip-
ments with limited agreement are inexistent. Systematic 
differences originating from the technology changes are, 
however, a major concern in longitudinal studies where 
the change in spirometric indices is the key health out-
come. According to our findings and those observed by 
Barr et al.  [11] , the systematic deviations are different for 
FEV 1 and FVC, thus, the potential for systematic biases 
in the FEV 1 /FVC ratio needs to be considered. The latter 
is crucial in the investigation of the incidence of chronic 
obstructive pulmonary disease and its determinants. 
While absolute differences observed in our comparison 
were generally ‘small’, we emphasize that many risks and 
treatments confer only ‘small’ but nevertheless relevant 
effects. Moreover, the shorter the follow-up time in lon-
gitudinal studies, the more influential are systematic dif-
ferences that originate from the change in technologies. 
In investigating health effects of air pollution, SAPAL-
DIA further faces the challenge that contrasts in exposure 
Table 3.  Comparisons between SM and EO spirometers derived from analyses of spirometric parameters measured in 82 healthy, non-
smoking volunteers
Spirometry
variables
EO1 EO2  EO3
mean
difference
mean
relative 
difference
Bland-Altman
95% limits of 
agreement
mean
difference*
mean
relative
difference
Bland-Altman
95% limits of 
agreement
mean 
difference*
mean
relative
difference
Bland-Altman
95% limits of 
agreement
FVC –0.13 litersa –2.80% –0.45 to 0.17 –0.02 liters –0.54% –0.33 to 0.27 –0.07 litersa –1.34% –0.37 to 0.23
FEV1 –0.10 litersa –2.33% –0.39 to 0.20 –0.01 liters 0.03% –0.28 to 0.26 –0.06 litersa –1.26% –0.41 to 0.29
FEV1/FVC 0.01c 0.50% –4.02 to 4.77 0.00c 0.60% –4.21 to 5.13 0.00 0.08% –4.74 to 4.74
FEF25–75 –0.02 l/s 0.14% –0.76 to 0.69 0.08 l/sb 2.87% –0.69 to 0.84 –0.00 l/s 0.11% –0.73 to 0.67
 Mean difference = EO – SM readings. Analysis: mixed-effect models with a random intercept by subject using the device as fixed effect adjusted for sex, 
age, height and sequence of spirometric tests. Heteroscedasticity was taken into account except for FEV1. Mean relative difference (%) = (EO – SM)/SM*100. 
a p < 0.001; b p < 0.01; c p < 0.05. EO1 (serial No. 67598); EO2 (serial No. 74745) and EO3 (serial No. 74747) were used.
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having been moderate to begin with further decrease due 
to clean air policies. Thus, it will be essential to find in-
novative solutions for correcting the systematic differ-
ences due to the inevitable change in technology. As 
shown in our assessment, the agreement also depended 
on the volume, thus, corrections of data collection with 
different devices may not be a fixed value but require 
some more complex models. This may involve the devel-
opment of further methods.
 Sources of error affecting the spirometric results can 
be multifold and linked to the device, the technician or 
the subject being examined. Several features differ be-
tween the two spirometer types that were compared. For 
example, recommended mouthpieces equipped with fil-
ters are rigid for the SM, but fairly soft pliable spirettes 
were proposed for the EO in earlier models. Barr et al. 
 [11] tested the effect of the mouthpiece compression, 
which had no significant effect on FEV 1 . Moreover, our 
EO models were equipped with rigid spirettes, which are 
unlikely to have influenced the results. However, one dis-
advantage of handheld spirometers is the fact that it is the 
subject performing the test who handles the device, and 
during the SAPALDIA examinations we had observed a 
marked tendency of study participants to bend front-
wards while performing the forced expiration. This could 
potentially introduce bias for lung function measure-
ments. For example, patients with chronic obstructive 
pulmonary disease may be more likely to bend in order to 
fully exhale. On the other hand, bending during the test 
could potentially hold back expiration and decrease the 
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Fig. 1. Bland-Altman plots showing the agreement between SM (reference) and EO spirometers for FVC (this 
page) and FEV 1 (next page). The middle line is the mean difference and the two extreme lines are the limits of 
agreement (±1.96 × SD) of differences between spirometers.
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Table 4.  Pairwise comparisons of the 3 EO spirometers derived from analyses of spirometric parameters measured in 82 healthy, non-
smoking volunteers
 Spirometry
 variables
EO2-EO1 EO3-EO1 EO3-EO2
mean
difference
mean
relative
difference
Bland-Altman
95% limits of 
agreement
mean
difference
mean
relative
difference
Bland-Altman
95% limits of 
agreement
mean
difference
mean 
relative 
difference
Bland-Altman
95% limits of 
agreement
FVC 0.10 litersa 2.39% –0.14 to 0.35 0.06 litersa 1.50% –0.09 to 0.22 –0.04 litersb –1.48% –0.35 to 0.21
FEV1 0.09 litersa 2.50% –0.15 to 0.34 0.03 liters 1.67% –0.09 to 0.21 –0.04 litersb –1.86% –0.36 to 0.21
FEV1/FVC –0.04 0.10% –2.84 to 3.01 –0.35 0.18% –2.95 to 3.27 –0.31 –0.40% –4.20 to 3.47
FEF25-75 0.10 l/sa 2.94% –0.38 to 0.60 0.02 l/s 2.04% –0.40 to 0.53 –0.08 l/sc –2.58% –0.69 to 0.47
 Mean difference = EO – SM readings. Analysis: mixed-effect models with a random intercept by subject using the device as fixed effect adjusted for sex, 
age, height and sequence of spirometric tests. Heteroscedasticity was taken into account except for FEV1. Mean differences: EO1 is the reference in differ-
ences calculated with EO2 or EO3; EO2 is the reference in differences calculated with EO3. Analysis: mixed-effect models with a random intercept by subject 
using the device as fixed effect adjusted for sex, age, height and sequence of spirometric tests. Heteroscedasticity was taken into account except for FEV1.  
Mean relative difference (%) = (EO2 – EO1)/EO1*100.  a p < 0.001; b p < 0.01; c p < 0.05. 
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FEV 1 , an artifact that would be less likely with the SM due 
to its voluminous and standstill format. Technicians in 
our study were trained to visually control the subjects be-
ing tested and coach them to prevent bending; however, 
uncontrollable minor bending may occur and systemati-
cally affect spirometric values. Finally, sources of error 
related to compliance during spirometry are crucial. Re-
peated spirometries done with the same device did not 
reveal significant differences, thus suggesting that the dis-
crepancies observed between devices were rather related 
to the specific technical characteristics of the 2 spirome-
ters than to compliance during tests.
 In this study, we were able to expand previous work 
evaluating the EO spirometer by assessing the interdevice 
reproducibility of this instrument. Our pairwise compari-
sons analyzing 3 EO devices show relatively small average 
differences between devices of the same brand with limits 
of agreement generally found within accepted limits for 
the FVC and the FEV 1 . Nonetheless, the significant statis-
tical differences found between devices with values reach-
ing the considered limits notably for FVC warrants cau-
tion when interpreting individual results from spirome-
tries performed with different devices of the same brand. 
While less relevant in epidemiological analyses – where 
adjustment for ‘device’ can be done – this may be relevant 
in clinical settings and decision making. In addition, as 
described above for comparisons between SM and EO, 
generally higher limits of agreement were found for FEF 25–
75 , but the absence of specific limits precludes further in-
terpretation of the results obtained for this parameter.
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Fig. 2. Bland-Altman plots showing the agreement between SM (reference) and EO spirometers for FEV 1 /FVC 
(this page) and FEF 25–75 (next page). The middle line is the mean difference and the two extreme lines are the 
limits of agreement (±1.96 × SD) of differences between spirometers.
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 Strengths of the study were the randomized design and 
the systematic sequential spirometries effectuated by a 
single experienced technician and performed by a rela-
tively large number of highly motivated healthy never-
smokers equally distributed according to sex. However, 
the study has also several limitations. First, our findings 
derive from examinations of healthy volunteers, mostly 
young adults, so the results might not apply to other 
groups, e.g. elderly patients with respiratory diseases and 
impaired lung function. We found indeed that the level of 
agreement significantly depends on the lung volumes – 
also a proxy for age – as shown in the Bland-Altman plots. 
This was in particular the case in the comparisons between 
SM and 1 EO for FVC, FEV 1 and FEF 25–75 . Second, only 1 
of the formerly used SM of SAPALDIA was available for 
testing. Although previous comparisons had not revealed 
major differences across the 8 SM devices, we cannot as-
sure that results would be as reproducible 10 years later for 
all devices. Third, we did not test spirometers using a 
waveform generator, a reproducibility testing procedure 
of equipment that does not involve test persons [29]. This 
was not a feasible option in our case . This test cannot take 
into account differences that may occur due to subject-
related factors (e.g. ability to comply with instructions or 
bending). Previous work had tested the same spirometer 
brands as those used in our study with good reproducibil-
ity of in-line testing using a mechanical generator  [11] ; 
moreover, after testing 24 subjects, the authors found sim-
ilar differences between spirometers as in our study. We 
were able to confirm these results in a larger study cohort. 
 In conclusion, our findings show overall good agree-
ment between the conventional SM and the handheld EO 
spirometers, as well as between EO devices. For clinical 
diagnosis and follow-up of individual patients, differences 
between the two spirometer types and among EO spirom-
eters can be considered as clinically mostly irrelevant. For 
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cohort studies, however, measuring for instance system-
atically lower FVC and FEV 1 at follow-up, even in case of 
very small amounts, may be falsely interpreted as acceler-
ated lung function decline of the population under study. 
This may lead to erroneous conclusions about the effect of 
environmental, biologic or life-style factors on lung func-
tion changes. In this case, the development of methods to 
adjust for systematic differences will be needed.
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